Explore how India's 20-year product patent regime transformed its pharma industry from generics to innovation, the economic ...

The Federal Circuit recently considered the scope of a permanent injunction that prohibited a drug manufacturer from ...

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...